LỜi cảM ƠN Đầu tiên, em xin bày tỏ lòng kính trọng và biết ơn sâu sắc đến cố pgs. Ts. Trần Công Yên

TÀI LIỆU THAM KHẢO

2. Nguyễn Hoàng Hải, Chế tạo và ứng dụng hạt nano từ tính trong Y sinh, Báo cáo hội nghị Vật lý toàn quốc (2007).

3. Trần Đức Quang, Nguyên lý và kĩ thuật chụp cộng hưởng từ (2007), NXB ĐHQG TP Hồ Chí Minh.
TÀI LIỆU TIẾNG ANH
4. Alexiou C. and Jurgons R. (2007), “Magnetic drug targeting”, Magnetism in medicine: a handbook, second edition, edited by W. Andra and H. Howak, Willey, Berlin, pp. 597-605.

5. Alexiou C., Arnold W., Klein R. J., Parak F. G., Hulin P., Bergemann C., Erhardt W., Wagenpfeil S., and Lubbe A. S. (2000), “Locoregional cancer treatment with magnetic drug targeting”, Cancer Res., 60, pp. 6641–6648.

6. Allen L. M., Kent J., Wolfe C., Ficco C., and Johnson J. (1997), “MTC^TM: a magnetically targetable drug carrier for paclitaxel”, Scientific and clinical applications of magnetic carriers, edited by Hafeli U., Schutt W., Teller J., and Zborowski M., Plenum Press, New York, London, pp. 481-494.

7. Chan D.C.F., Kirpotin D.B., Bunn P.A. (1993), “Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer”, J. Magn. Magn. Mater., 122, pp. 374-378.

8. Gilchrist R.K., Medal R., Shorey W.D., Hanselman R.C., Parrot J.C., and Talor C.B. (1957), “Sellective inductive heating of lymph nodes”, Ann. Surgery, 146, pp. 596-606.

9. Gneveckow U., Jordan A., Scholz R., Brub V., Waldofner N., Ricke J., Feussner A., Hildebrandt B., Rau B., and Wust P. (2004), “Description and characterization of the novel hyperthermia- and thermoablation-system MFH300F for clinical magnetic fluid hyperthermia”, Med. Phys., 31, pp. 1444-1451.

10. Gneveckow U., Jordan A., Scholz R., Eckelt L., Maier-Hauff K., Johannsen M., and Wust P. (2005), “Magnetic force nanotherapy: with nanoparticles against cancer. Experiences from three clinical trials”, Biomed. Techn., 50, pp. 92-93.

11. Gordon R.T., Hines J.R., Gordon D. (1979), “Intracellular hyperthermia: a biophysical approach to cancer treatment via intracellular temperature and biophysical alterations”, Medical Hypothesis 5, pp. 83-102.

12. Govind B Chavhan, MRI made easy, Hospital for Sick Children, Toronto, Canada.

13. Hafeli U. and Pauer G.J. (1999), “In vitro and in vivo toxicity of magnetic microspheres”, J. Magn. Magn. Mater. 194, pp. 76.

14. Hai, N.H., R. Lemoine, S. Remboldt, M. Strand, J.E. Shield, D. Schmitter, R.H. Kraus Jr., M. Espy, and D.L. Leslie-Pelecky, J. Magn. Magn. Mater., 293 (2005) 75.

15. Handy E.S., Ivkov R., Ellis-Busby D., Foreman A., Braunhut S.J., Gwost D.U., and Ardman B. (2003), “Thermo-therapy via targeted delivery of nanoscale magnetic particles”, US Patent Appl. Publ. US2003/0032995.

16. Hergt R., Andra W., d’Ambly C.G., Hilger I., Kaiser W.A., Richter U., and Schmidt H. (1998), “Physical limits of hyperthermia using magnetite fine particles”, IEEE Trans. Magn., 34, pp. 3745-3754.

17. Johannsen M., Gneveckow U., Eckelt L., Feussner A., Waldofner N., Scholz R., Deger S., Wust P., Loening S.A., and Jordan A. (2005), “Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique”, Int. J. Hyperthermia, 21:7, pp. 637-647.

18. Johannsen M., Gneveckow U., Taymoorian K., Cho H.C., Thiesen B., Scholz R., Waldofner N., Loening S.A., Wust P., and Jordan A. (2007), “Thermal therapy of prostate cancer using magnetic nanoparticles”, Actas Urol Esp., 31, pp. 660-667

19. Johannsen M., Gneveckow U., Taymoorian K., Thiesen B., Waldofner N., Scholz R., Jung K., Jordan A., Wust P., and Loening S.A. (2007), “Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial”, Int. J. Hyperthermia, 23:3, pp. 315-323.

20. Johannsen M., Gneveckow U., Thiesen B., Taymoorian K., Cho C.H., Waldofner N., Scholz R., Jordan A., Loening S.A., and Wust P. (2007), “Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution”, European urology, 52, pp. 653-662.

21. Jordan A., Scholz R., Wust P., Fahling H., Krause J., Wlodarczyk W., Sander B., Vogl T., and Felix R. (1997), “Effects of magnetic fluid hyperthermia on C3H mammary carcinoma in vivo”, Int. J. Hyperthermia, 13, pp. 587.

22. Jordan A., Wust P., Scholz R., Fahling H., Krause J., and Felix R. (1997), “Magnetic fluid hyperthermia”, Scientific and clinical applications of magnetic carriers, edited by Hafeli U., Schutt W., Teller J., and Zborowski M., Plenum Press, New York, London, pp. 569-595.

23. Kuznietsov A., Harutyunyan A. R., Dobrinski E. K., Filipov V. I., Malenkov A. G., Vanin A. F., and Kuznietsov O. A (1997), “Ferro-carbon particles: preparation and clinical applications”, Scientific and clinical applications of magnetic carriers, edited by Hafeli U., Schutt W., Teller J., and Zborowski M., Plenum Press, New York, London, pp. 379-389.

24. Leslie-Pelecky, D.L., V. Labhasetwar, and J. Kraus, R.H., Nanobiomagnetics, in Advanced Magnetic Nanostructures, D.J. Sellmyer and R.S. Skomski, Editors. 2005, Kluwer: New York.

25. Lubbe A. S., Bergemann C., Brock J., and McClure D. G. (1999), “Physiological aspects in magnetic drug-targeting”, J. Magn. Magn. Mater., 194, pp. 149–55.

26. Mornet S., Vasseur S., Grasset F., and Duguet E. (2004), “Magnetic nanoparticle design for medical diagnosis and therapy”, J. Mater. Chem., 14, pp. 2161-2175.

27. Moroz P., Jones S. K., Gray B. N. (2002), “Magnetically mediated hyperthermia: current status and future direction”, Int. J. Hyperthermia, 18, pp. 267.

28. Neuberger T., Schopf B., Hofmann H., Hofmann M., and Rechenberg B. (2005), “Superparamagnetic nanoparticles for biomedical applications”, J. Magn. Magn. Mater., 293, pp. 483.

29. Pankhurst Q. A., Connolly J., Jones S. K., and Dobson J. (2003), “Applications of magnetic nanoparticles in biomedicine”, J. Phys. D: Appl. Phys., 36, pp. 167-181.

30. Pitot H. C (2002), Fundametal of oncology, Marcel Dekker Publisher, pp. 770.

31. Rabin Y. (2002), “Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?”, Int. J. Hyperthermia, 18, pp. 194-199.

32. Rand R.W., Snow H.D., Elliott D.G., and Haskins G.M. (1985), “Induction heating method for use in causing necrosis of neoplasm”, US Patent 4, 545, 368.

33. Rosensweig, R.E., Ferrohydrodynamics. 1985, Cambridge: Cambridge University Press.

34. Widder K. J., Morris R. M., Poore G. A., Howard D. P., and Senyei A. E. (1983), “Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin—total remission in Yoshida sarcoma-bearing rats”, Eur. J. Cancer Clin. Oncol., 19, pp.135–139.

35. Yanase M., Shinkai M., Honda H., Wakabayashi T., Yoshida J., and Kobayashi T (1998), “Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study”, Jpn. J. Cancer Res., 89, pp. 463-469.